miR-140-3p enhances the sensitivity of LUAD cells to antitumor agents by targeting the ADAM10/Notch pathway

Background: The Notch pathway, which is related to the drug-resistance of lung adenocarcinoma (LUAD) type of non-small cell lung cancer (NSCLC) cells, is activated by cleavage of Notch proteins mediated by ADAMs, ADAM10 or ADAM17. Methods: In the present study, our results demonstrated that of these...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Hao, Li, Bo, Xu, Wei, Ding, Renquan, Xu, Shiguang, Wu, Qiong, Zhang, Yingshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809315/
https://www.ncbi.nlm.nih.gov/pubmed/36606198
http://dx.doi.org/10.7150/jca.78835

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809315/
https://www.ncbi.nlm.nih.gov/pubmed/36606198
http://dx.doi.org/10.7150/jca.78835

Ejemplares similares